In vitro binding and signaling profile of the novel μ opioid receptor agonist endomorphin 2 in rat brain membranes

Biochemical and Biophysical Research Communications

Volumn 250, Issue 3, 1998, Pages 720-725

  Spetea, Mariana ^a   Monory, Krisztina ^a   Tömböly, Csaba ^a   Tóth, Géza ^a   Tzavara, Eleni ^b   Benyhe, Sándor ^a   Hanoune, Jacques ^b   Borsodi, Anna ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BRAIN RECEPTOR; CYPRODIME; DELTORPHIN; ENDOMORPHIN 2; ENDORPHIN DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MEMBRANE RECEPTOR; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NALTRINDOLE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STEREOSPECIFICITY;

ANIMALIA;

EID: 0032578605     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.9395     Document Type: Article

References (42)

1. Zadina J. E., Hackler L., Ge L.-J., Kastin A. J. Nature. 386:1997;499-502.
2. Higashida H., Hoshi N., Knijnik R., Zadina J. E., Kastin A. J. J. Physiol. (London). 50:1997;71-75.
3. Champion H. C., Zadina J. E., Kastin A. J., Hackler L., Ge L. J., Kadowitz P. J. Biochem. Biophys. Res. Commun. 235:1997;567-570.
4. Champion H. C., Zadina J. E., Kastin A. J., Kadowitz P. J. Life Sci. 61:1997;PL409-415.
5. Champion H. C., Zadina J. E., Kastin A. J., Hackler L., Ge L. J., Kadowitz P. J. Peptides. 18:1997;1393-1397.
6. Stone L. S., Fairbanks C. A., Laughlin T. M., Nguyen H. O., Bushy T. M., Wessendorf M. W., Wilcox G. L. NeuroReport. 8:1997;3131-3135.
7. Martin-Schild S., Zadina J. E., Gerall A. A., Vigh S., Kastin A. J. Peptides. 18:1997;1641-1649.
8. Hackler L., Zadina J. E., Ge L. J., Kastin A. J. Peptides. 18:1997;1635-1639.
9. Sim L. J., Liu Q., Childers S. R., Selley D. E. J. Neurochem. 70:1998;1567-1576.
10. Burford N. T., Tolbert L. M., Sadee W. Eur. J. Pharmacol. 342:1998;123-126.
11. Hosohata K., Burkey T. H., Alfaro-Lopez J., Varga E., Hruby V. J., Roeske W. R., Yamamura H. I. Eur. J. Pharmacol. 346:1998;111-114.
12. Standifer K. M., Pasternak G. W. Cell Signal. 9:1997;237-248.
13. Traynor J. R., Nahorski S. R. Mol. Pharmacol. 47:1995;848-854.
14. Sasaki Y., Ambo A., Suzuki K. Biochem. Biophis. Res. Commun. 180:1991;822-827.
15. Tóth G., Lovas S., Ötvös F. Methods in Molecular Biology, Neuropeptides Protocols. 1997;Humana Press, Totowa. p. 19-23.
16. Schmidhammer H., Burkard W. P., Eggstein-Aeppli L., Smith C. F. C. J. Med. Chem. 32:1989;418-421.
17. Tóth G., Kramer M., Sirokmán F., Borsodi A., Rónai A. J. Labelled Comp. Radiopharm. 19:1982;1021-1030.
18. Ötvös F., Tóth G., Schmidhammer H. Helvetica Chimica Acta. 75:1992;1718-1720.
19. Tóth G., Ötvös F., Hosztafi S. Helvetica Chimica Acta. 76:1993;2274-2278.
20. Nevin S. T., Kabasakal L., Ötvös F., Tóth G., Borsodi A. Neuropeptides. 26:1994;261-265.
21. Tömböly Cs., Spetea M., Borsodi A., Tóth G. Cz. J. Physics. 1998.
22. Simon J., Benyhe S., Abutidze K., Borsodi A., Szûcs M., Wollemann M. J. Neurochem. 46:1986;695-701.
23. Bradford M. M. Anal. Biochem. 72:1976;248-254.
24. Weiland G. A., Molinoff P. B. Life Sci. 29:1981;313-330.
25. Munson P. J., Rodbard D. Anal. Biochem. 107:1980;220-239.
26. Leatherbarrow, R. J. 1992, GraFit Version 3.0, 1, 287, Erithacus Software Ltd. Staines, UK.
27. Selley D. A., Breivogel C. S., Childers S. R. Mol. Pharmacol. 44:1993;731-741.
28. Matsuoka I., Giuili G., Poyard M., Stengel D., Parma J., Guellaen G., Hanoune J. J. Neurosci. 12:1992;3350-3360.
29. Lord J. A., Waterfield A. A., Hughes J., Kosterlitz H. W. Nature. 267:1977;495-499.
30. Chavkin C., Goldstein A. Proc. Natl. Acad. Sci. USA. 78:1981;6543-6547.
31. Pert C. B., Snyder S. H. Mol. Pharmacol. 10:1974;868-879.
32. Sakaguchi K., Shimohigashi Y., Waki M., Kato T., Costa T., Herz A. Shiba T., Sakakibara S. Peptide Chemistry 1987. 1988;577-580 Protein Research Foundation, Osaka.
33. Spetea M., Ötvös F., Tóth G., Nguyen T. M.-D., Schiller P. W., Vogel Z., Borsodi A. Peptides. 1998.
34. Delay-Goyet P., Seguin C., Gacel G., Roques B. P. J. Biol. Chem. 263:1988;4124-4130.
35. Blanchard S. G., Lee P. H., Pugh W. W., Hong J. S., Chang K.-J. Mol. Pharmacol. 31:1987;326-333.
36. Amiche M., Sagan S., Mor A., Delflor A., Nicolas P. Int. J. Peptide Protein Res. 32:1988;506-511.
37. Monteillet-Agius G., Fein J., Phan T., Anton B., Lam H., Zaki P., Miotto K., Evans C. J. Proc. West Pharmacol. Soc. 39:1996;69-70.
38. Kramer T. H., Shook J. E., Kazmierski W., Ayres E. A., Wire W. S., Hruby V. J., Burks T. F. J. Pharmacol. Exp. Ther. 249:1989;544-551.
39. Carter B. D., Medzihradsky F. Proc. Natl. Acad. Sci. USA. 90:1993;4062-4066.
40. Zajac J. M., Roques B. P. J. Neurochem. 44:1985;1605-1614.
41. Yamamura M. S., Horvath R., Tóth G., Ötvös F., Malatynska E., Knapp R. J., Porreca F., Hruby V. J., Yamamura H. I. Life Sci. 50:1992;PL-119-PL-124.
42. Lahti R. A., Mickelson M. M., McCall J. M., Von Voigtlander P. F. Eur. J. Pharmacol. 109:1985;281-284.